Advertisement
LSTA vs PYPD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSTA is a Buy and PYPD is a StrongBuy.
LSTA sees its Stochastic Oscillator ascending out of oversold territory
On October 27, 2026, the Stochastic Oscillator for LSTA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 60 instances where the indicator left the oversold zone. In 53 of the 60 cases the stock moved higher in the following days. This puts the odds of a move higher at over 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LSTA's RSI Oscillator exited the oversold zone, 29 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Moving Average Convergence Divergence (MACD) for LSTA just turned positive on October 26, 2026. Looking at past instances where LSTA's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
Following a +5.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where LSTA advanced for three days, in 189 of 228 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
LSTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LSTA as a result. In 85 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
LSTA moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for LSTA crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LSTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for LSTA entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.389) is normal, around the industry mean (2.974). P/E Ratio (-0.646) is within average values for comparable stocks, (-0.899). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (135.903) among similar stocks. P/S Ratio (131.579) is also within normal values, averaging (439.237).
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. LSTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LSTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
PYPD's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for PYPD turned positive on October 22, 2026. Looking at past instances where PYPD's MACD turned positive, the stock continued to rise in 43 of 51 cases over the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on PYPD as a result. In 107 of 128 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
PYPD moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +9.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where PYPD advanced for three days, in 180 of 219 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for PYPD crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PYPD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
PYPD broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PYPD entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. PYPD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.752) is normal, around the industry mean (2.974). P/E Ratio (-4.405) is within average values for comparable stocks, (-0.899). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (135.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.237).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PYPD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
LSTA | PYPD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 63 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 65 Fair valued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 100 | |
PRICE GROWTH RATING 1..100 | 87 | 38 | |
P/E GROWTH RATING 1..100 | 7 | 56 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LSTA's Valuation (65) in the null industry is in the same range as PYPD (86). This means that LSTA’s stock grew similarly to PYPD’s over the last 12 months.
LSTA's Profit vs Risk Rating (100) in the null industry is in the same range as PYPD (100). This means that LSTA’s stock grew similarly to PYPD’s over the last 12 months.
LSTA's SMR Rating (99) in the null industry is in the same range as PYPD (100). This means that LSTA’s stock grew similarly to PYPD’s over the last 12 months.
PYPD's Price Growth Rating (38) in the null industry is somewhat better than the same rating for LSTA (87). This means that PYPD’s stock grew somewhat faster than LSTA’s over the last 12 months.
LSTA's P/E Growth Rating (7) in the null industry is somewhat better than the same rating for PYPD (56). This means that LSTA’s stock grew somewhat faster than PYPD’s over the last 12 months.
| LSTA | PYPD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 88% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 88% | 1 day ago 83% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 84% |
| MACD ODDS (%) | 1 day ago 79% | 1 day ago 84% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 83% |
| Advances ODDS (%) | 7 days ago 83% | 1 day ago 82% |
| Declines ODDS (%) | 5 days ago 85% | 14 days ago 84% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 78% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LSTA’s FA Score shows that 1 FA rating(s) are green while PYPD’s FA Score has 0 green FA rating(s).
- LSTA’s FA Score: 1 green, 4 red.
- PYPD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LSTA’s TA Score shows that 5 TA indicator(s) are bullish while PYPD’s TA Score has 4 bullish TA indicator(s).
- LSTA’s TA Score: 5 bullish, 5 bearish.
- PYPD’s TA Score: 4 bullish, 6 bearish.
Price Growth
LSTA (@Biotechnology) experienced а -1.92% price change this week, while PYPD (@Biotechnology) price change was +12.04% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.36%. For the same industry, the average monthly price growth was -13.16%, and the average quarterly price growth was -14.28%.
Reported Earning Dates
LSTA is expected to report earnings on Nov 05, 2026.
PYPD is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Biotechnology (-1.36% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
LSTA and
Correlation & Price change
A.I.dvisor tells us that LSTA and RAIN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and RAIN's prices will move in lockstep.
| Ticker / NAME | Correlation To LSTA | 1D Price Change % | ||
|---|---|---|---|---|
| LSTA | 100% | -3.77% | ||
| RAIN - LSTA | 29% Poorly correlated | +8.49% | ||
| PYPD - LSTA | 29% Poorly correlated | +9.07% | ||
| MLEC - LSTA | 27% Poorly correlated | -3.29% | ||
| ASND - LSTA | 26% Poorly correlated | +0.29% | ||
| AMLX - LSTA | 25% Poorly correlated | +4.47% | ||
More | ||||
PYPD and
Correlation & Price change
A.I.dvisor tells us that PYPD and AMLX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and AMLX's prices will move in lockstep.
| Ticker / NAME | Correlation To PYPD | 1D Price Change % | ||
|---|---|---|---|---|
| PYPD | 100% | +9.07% | ||
| AMLX - PYPD | 29% Poorly correlated | +4.47% | ||
| SYRE - PYPD | 29% Poorly correlated | +6.60% | ||
| TSHA - PYPD | 28% Poorly correlated | +5.99% | ||
| INM - PYPD | 28% Poorly correlated | N/A | ||
| FENC - PYPD | 28% Poorly correlated | +4.63% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SCA | 25.32 | 0.92 | +3.75% |
| GraniteShares Autocallable SMCI ETF (SCA) | |||
| BILT | 27.90 | 0.18 | +0.65% |
| iShares Infrastructure Active ETF (BILT) | |||
| SCD | 15.06 | 0.05 | +0.33% |
| LMP Capital and Income Fund | |||
| CPSR | 26.29 | 0.02 | +0.08% |
| Calamos S&P 500 Structured Alt Protection ETF - March | |||
| TMF | 29.64 | -0.06 | -0.20% |
| Direxion Daily 20+ Year Treasury Bull 3X ETF (TMF) | |||